Condition: Old World Cutaneous Leishmaniasis · Sponsor: Medecins Sans Frontieres, Netherlands
randomised control clinical trial to evaluate miltefosine, thermotherapy and the combination miltefosine-thermotherapy are effective, safe and tolerable alternative treatment options to treat cutaneous leishmaniasis caused by L. tropica, in Pakistan compared to the standard of care.
This description comes directly from the study's public registry record.
Suzette Sabine Kämink · +31643690015 · s.s.kamink@gmail.com
Koert Ritmeijer · +31 6 24453143 · koert.ritmeijer@oca.msf.org
Always discuss trial participation with your own doctor first.
| Kuchlak Primary Health Care Centre (MCH) | Kuchlagh, Balochistan, Pakistan | Recruiting |
| Shaheed Mohtarma Benazir Bhutto General Hospital | Quetta, Balochistan, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04268524